On July 2, MetLife rose 3.16% in regular trading, trading at $87.27/share, with turnover of $89.89 million.

On the news front, MetLife filed with the SEC on June 29 disclosing that Q2 pre-tax variable investment income is expected to range between $220 million and $270 million, while maintaining its full-year guidance of $1.6 billion. Combined with Q1 actual variable investment income of $518 million — which represented a 58% year-over-year increase driven by improved private equity returns — the first-half total is projected at approximately $738 million to $788 million, representing 46% to 49% of the annual target. This pace indicates solid execution toward the full-year objective.

The company is scheduled to release its complete Q2 earnings on August 5, with consensus EPS estimates at $2.44. Analyst sentiment remains broadly constructive, with the average rating at overweight and a mean price target of approximately $93.73. Recent target price adjustments include Piper Sandler raising to $90 and Argus raising to $93, both maintaining positive ratings.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)